| AstraZeneca AG - Ondexxya 200 mg, Pulver zur Herstellung einer Infusionslösung | | 67759 | | 01 | | Ondexxya 200 mg | | Pulver zur Herstellung einer Infusionslösung | | V03AB38 | | Andexanet Alfa | | 02.12.2020 | | |
| | Composition | | andexanet alfa 200 mg, trometamolum, trometamoli hydrochloridum, arginini hydrochloridum, saccharum, mannitolum, polysorbatum 80, ad pulverem. | | Packungsbestandteile | | Lyophilisate | | | | | | Active Agent | Dose |
|---|
| Andexanet Alfa | 200 mg |
| | | | Inactive agents |
|---|
| Arginine Hydrochloride | | Mannitol | | Polysorbatum 80 | | Saccharum | | Trometamoli Hydrochloridum | | Trometamol |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 4 | | | A | | No | | 002 | 5 | | | A | | No |
|
|
